Wilmington, Del. – September 27, 2026 -- A new 51-jurisdiction dataset from Cuvo Health shows that only 14 states offer out-of-state physicians a telehealth registration or telemedicine license short of full licensure, exposing a costly compliance gap for digital health startups seeking national scale.
Madison, Wis. – September 27, 2026 -- Accuray Incorporated (NASDAQ: ARAY) has signed agreements with Samsung HME America's NeuroLogica Corp. unit to pursue advanced volumetric imaging capabilities for its CyberKnife System, the companies announced at the ASTRO Annual Meeting in Boston.
The collaboration pairs Samsung NeuroLogica's mobile computed tomography and volumetric imaging technology with Accuray's precision treatment delivery, robotic radiosurgery and motion-management systems. No commercial product has been announced; the partnership will proceed through phased technical, clinical and commercial evaluation subject to regulatory requirements.
Boston – September 27, 2026 -- Leo Cancer Care has confirmed a dedicated pediatric program combining education, distraction and gamification technology, following the world's first pediatric treatments delivered on its upright Marie® positioning and imaging platform.
Stanford Medicine treated the initial pediatric patients using the Mevion S250-FIT Proton Therapy System, which integrates Leo Cancer Care's Marie platform and RaySearch Laboratories' RayStation planning software. The early cases demonstrated that upright proton therapy is feasible across a wide pediatric age range, with anesthesia still available when clinically required.
Washington, D.C. – September 25, 2026 -- Monumental Sports & Entertainment (MSE) has donated $1.1 million to MedStar Health, extending a five-year philanthropic commitment first pledged in 2024 to fund maternal, infant and pediatric care programs across Washington, D.C.
The gift continues annual support MSE committed in 2024 to expand access to specialized health services for birthing mothers and children in the District. Since 2019, MSE and The Leonsis Family have contributed more than $13 million to MedStar Health initiatives, including pediatric community health, COVID-19 response and sports medicine programs.
Pune – – September 25, 2026 -- The global N95 mask market is projected to grow from $3.27 billion in 2025 to $11.08 billion by 2034, a 14.52% compound annual growth rate, according to Maximize Market Research.
North America held the largest regional share in 2025, driven by hospital demand, workplace safety mandates, and infection-control requirements. Manufacturers including 3M, Honeywell, Moldex-Metric, Cardinal Health, and Medline Industries maintain significant production presence in the region, supporting its lead position through continued investment in respiratory-protection capacity.
Pune, India – September 25, 2026 -- The global dietary supplements market was valued at USD 186.36 billion in 2025 and is forecast to reach USD 324.88 billion by 2034, expanding at a compound annual growth rate of 6.37% between 2026 and 2034, according to a new report from Maximize Market Research.
North America leads the global market, driven by high consumer spending on health and wellness, strong preventive healthcare awareness, and regulatory clarity that supports major dietary supplement manufacturers. The United States remains the largest contributor within the region, with strong uptake of vitamins, minerals, herbal supplements, probiotics, and sports nutrition products.
Kansas City, Mo. – September 25, 2026 -- Sun Life U.S. and the Kansas City Royals Foundation have completed the first "Every Single Smile" campaign, raising $50,000 to expand dental care access for underserved youth in Kansas City through nonprofit TeamSmile.
The campaign converted a core baseball statistic into a philanthropic mechanism, with each single hit by the Royals generating a contribution from Sun Life and the Kansas City Royals Foundation over the course of the season.
The $50,000 will support an additional TeamSmile dental clinic in Kansas City this December and strengthen the Dental Home Project, which links underserved youth with local dentists for ongoing preventive care relationships.
Kenai, Alaska – September 25, 2026 -- The Kenaitze Indian Tribe (KIT) has begun notifying individuals whose protected health information may have been compromised in a network intrusion detected on July 27, 2026.
KIT's investigation, conducted with cybersecurity specialists, determined that an unauthorized party gained access to the tribe's network between July 16 and July 27, 2026, and may have accessed or downloaded certain files during that window.
A comprehensive file review identified that compromised information may include first and last names, Social Security numbers, driver's license or state identification numbers, financial account numbers, dates of birth, medical information, and health insurance details.
Washington – September 25, 2026 -- A bipartisan bill introduced in the U.S. Senate would create the Heart Security Foundation, a federally chartered nonprofit housed within the National Institutes of Health to accelerate cardiovascular research funding and coordination.
Cardiovascular disease remains the leading cause of death in the United States, claiming close to one million lives each year, according to figures cited in the legislative push. Roughly 120 million American adults -- nearly one-third of the U.S. population -- are living with some form of cardiovascular disease, with risk levels disproportionately distributed across communities.
Springfield, Mass. – September 25, 2026 -- Baystate Health has become the first hospital in the United States to enroll patients in the PIONEER trial, a national study evaluating Balt Corporation's Silk Vista Baby flow-diverting stent for unruptured brain aneurysms in small blood vessels, treating its first three patients within days of receiving approval.
The PIONEER study is a prospective, multicenter, single-arm trial spanning 35 leading centers in the United States and 5 in Canada, designed to assess the safety and efficacy of the Silk Vista Baby device. Balt Corporation launched the trial to satisfy FDA requirements for broader U.S. market access after the device received full approval from the Centers for Medicare & Medicaid Services following a prolonged review process.